<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-03836R2</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0003236</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Neurological Disorders</subject><subject>Neuroscience</subject><subject>Neurological Disorders/Alzheimer Disease</subject></subj-group></article-categories><title-group><article-title>A&#x003b2; Mediated Diminution of MTT Reduction&#x02014;An Artefact of Single Cell Culture?</article-title><alt-title alt-title-type="running-head">A&#x003b2;-MTT-Effect in Brain Slices</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>R&#x000f6;nicke</surname><given-names>Raik</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Klemm</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Meinhardt</surname><given-names>Jessica</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schr&#x000f6;der</surname><given-names>Ulrich H.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>F&#x000e4;ndrich</surname><given-names>Marcus</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Reymann</surname><given-names>Klaus G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Project Group Neuropharmacology, Leibniz Institute for Neurobiology, Magdeburg, Germany</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Research Institute for Applied Neurosciences GmbH, Magdeburg, Germany</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Leibniz Institute for Age Research (Fritz Lipmann Institute), Jena, Germany</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Max Planck Research Unit for Enzymology of Protein Folding, Halle (Saale), Germany</addr-line></aff><aff id="aff5"><label>5</label><addr-line>Martin-Luther University Halle-Wittenberg, Halle, Germany</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Lashuel</surname><given-names>Hilal</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Swiss Federal Institute of Technology Lausanne, Switzerland</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>roenicke@zenit-magdeburg.de</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: MF KGR. Performed the experiments: RR AK JM. Analyzed the data: RR. Contributed reagents/materials/analysis tools: JM. Wrote the paper: RR UHS.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>18</day><month>9</month><year>2008</year></pub-date><volume>3</volume><issue>9</issue><elocation-id>e3236</elocation-id><history><date date-type="received"><day>5</day><month>3</month><year>2008</year></date><date date-type="accepted"><day>26</day><month>8</month><year>2008</year></date></history><copyright-statement>R&#x000f6;nicke et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><p>The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazoliumbromide (MTT) reduction assay is a frequently used and easily reproducible method to measure beta-amyloid (A&#x003b2;) toxicity in different types of single cell culture. To our knowledge, the influence of A&#x003b2; on MTT reduction has never been tested in more complex tissue. Initially, we reproduced the disturbed MTT reduction in neuron and astroglia primary cell cultures from rats as well as in the BV2 microglia cell line, utilizing four different A&#x003b2; species, namely freshly dissolved A&#x003b2; (25-35), fibrillar A&#x003b2; (1-40), oligomeric A&#x003b2; (1-42) and oligomeric A&#x003b2; (1-40). In contrast to the findings in single cell cultures, none of these A&#x003b2; species altered MTT reduction in rat organotypic hippocampal slice cultures (OHC). Moreover, application of A&#x003b2; to acutely isolated hippocampal slices from adult rats and <italic>in vivo</italic> intracerebroventricular injection of A&#x003b2; also did not influence the MTT reduction in the respective tissue. Failure of A&#x003b2; penetration into the tissue cannot explain the differences between single cells and the more complex brain tissue. Thus electrophysiological investigations disclosed an impairment of long-term potentiation (LTP) in the CA1 region of hippocampal slices from rat by application of oligomeric A&#x003b2; (1-40), but not by freshly dissolved A&#x003b2; (25-35) or fibrillar A&#x003b2; (1-40). In conclusion, the experiments revealed a glaring discrepancy between single cell cultures and complex brain tissue regarding the effect of different A&#x003b2; species on MTT reduction. Particularly, the differential effect of oligomeric versus other A&#x003b2; forms on LTP was not reflected in the MTT reduction assay. This may indicate that the A&#x003b2; oligomer effect on synaptic function reflected by LTP impairment precedes changes in formazane formation rate or that cells embedded in a more natural environment in the tissue are less susceptible to damage by A&#x003b2;, raising cautions against the consideration of single cell MTT reduction activity as a reliable assay in Alzheimer's drug discovery studies.</p></abstract><counts><page-count count="9"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Deposits of beta-amyloid (A&#x003b2;) and neurofibrillary tangles are the two pathological hallmarks of Alzheimer's disease. There is recent evidence that soluble A&#x003b2; aggregates can impair function, morphology and subsequently the viability of neuronal cells <xref ref-type="bibr" rid="pone.0003236-Walsh1">&#x0005b;1&#x0005d;</xref>. Based on NADH dependent reduction activity, cells are able to reduce the tetrazolium salt MTT &#x0005b;3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide&#x0005d; into a formazane <xref ref-type="bibr" rid="pone.0003236-Liu1">&#x0005b;2&#x0005d;</xref>. Thus, it is widely accepted that the amount of formazane production correlates with both the number and the viability of the cells. The MTT assay is well established for investigations of cellular viability in single cell cultures <xref ref-type="bibr" rid="pone.0003236-Hayon1">&#x0005b;3&#x0005d;</xref> and tissue slices <xref ref-type="bibr" rid="pone.0003236-Latini1">&#x0005b;4&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Lushnikova1">&#x0005b;5&#x0005d;</xref>. The MTT assay is frequently used to evidence A&#x003b2; related changes in membrane properties and disturbed cellular viability <xref ref-type="bibr" rid="pone.0003236-Liu2">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Shearman1">&#x0005b;7&#x0005d;</xref>. The question how A&#x003b2; inhibits cellular MTT reduction is still a matter of debate. Based on their findings that A&#x003b2; potently inhibits cellular reduction of MTT in cultured rat hippocampal neurons and HeLa cell lines, Kaneko et al. (1995) have hypothesized that A&#x003b2; specifically suppresses mitochondrial succinate dehydrogenase <xref ref-type="bibr" rid="pone.0003236-Kaneko1">&#x0005b;8&#x0005d;</xref>. Studies on rat brain tumor cells <xref ref-type="bibr" rid="pone.0003236-Liu3">&#x0005b;9&#x0005d;</xref> and astrocytes <xref ref-type="bibr" rid="pone.0003236-Abe1">&#x0005b;10&#x0005d;</xref>, on the other hand, indicated that A&#x003b2; decreases cellular MTT reduction by accelerating the exocytosis of MTT formazan.</p><p>Although many <italic>in vitro</italic> findings on A&#x003b2; toxicity and competing, protective agents are based on the MTT assay <xref ref-type="bibr" rid="pone.0003236-Bieschke1">&#x0005b;11&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003236-Szegedi1">&#x0005b;14&#x0005d;</xref>, the influence of A&#x003b2; on MTT reduction has never been tested in more complex models than single cell cultures. Organotypic hippocampal slices (OHC) are an <italic>in vitro</italic> model that retains the three dimensional structure of <italic>in vivo</italic> systems and ranges in complexity between primary cell cultures and intact animals <xref ref-type="bibr" rid="pone.0003236-Sundstrom1">&#x0005b;15&#x0005d;</xref>. OHCs represent a well established tool for the investigation of brain damage due to oxygen glucose deprivation (OGD) <xref ref-type="bibr" rid="pone.0003236-Neumann1">&#x0005b;16&#x0005d;</xref> or epilepsy <xref ref-type="bibr" rid="pone.0003236-Noraberg1">&#x0005b;17&#x0005d;</xref>. When OHCs were exposed to very high doses of A&#x003b2; (&#x02265;10 &#x000b5;M) neuronal apoptotic cell death <xref ref-type="bibr" rid="pone.0003236-Imai1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Wang1">&#x0005b;19&#x0005d;</xref> and a pronounced activation of astrocytes <xref ref-type="bibr" rid="pone.0003236-Xu1">&#x0005b;20&#x0005d;</xref> occurred. More subtle submicromolar A&#x003b2; concentrations caused a retraction of neuronal dendrites and a degeneration of dendritic spines <xref ref-type="bibr" rid="pone.0003236-Shankar1">&#x0005b;21&#x0005d;</xref>. Although it has been shown that MTT is appropriate to evaluate the viability of brain tissue slices and its reduction is impaired after detrimental treatment, such as OGD <xref ref-type="bibr" rid="pone.0003236-Lushnikova1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Connelly1">&#x0005b;22&#x0005d;</xref>, the influence of A&#x003b2; on MTT reduction in OHCs has never been tested before.</p><p>In this study, we compared OHCs and primary cell cultures for the effect of different A&#x003b2; species, varying in molecule length and aggregation status, on MTT reduction. We used freshly dissolved A&#x003b2; (25-35), which is frequently used and already shown to exert detrimental effects on brain function and MTT reduction of single cells well before aggregation occurs <xref ref-type="bibr" rid="pone.0003236-Holscher1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Kato1">&#x0005b;24&#x0005d;</xref>. However, we can not exclude aggregation of A&#x003b2; (25-35) occurring during the experiment. Further, we used A&#x003b2; (1-40) fibrils, which are polypeptide aggregates, characterized by a fibrillar structure and the presence of a cross-&#x003b2; conformation <xref ref-type="bibr" rid="pone.0003236-Fandrich1">&#x0005b;25&#x0005d;</xref>. These fibrils were shown to impair cellular MTT reduction <xref ref-type="bibr" rid="pone.0003236-Shearman1">&#x0005b;7&#x0005d;</xref>. The third species tested were so-called &#x02018;oligomers&#x02019; of A&#x003b2; (1-42) <xref ref-type="bibr" rid="pone.0003236-Barghorn1">&#x0005b;26&#x0005d;</xref> and A&#x003b2; (1-40) <xref ref-type="bibr" rid="pone.0003236-Kayed1">&#x0005b;27&#x0005d;</xref>. These oligomers are small non-fibrillar aggregates that are defined by an almost spherical shape and that have been discussed to be early mediators of cellular malfunction within the Alzheimer afflicted brain <xref ref-type="bibr" rid="pone.0003236-Rowan1">&#x0005b;28&#x0005d;</xref>. Moreover, we analyzed the influence of freshly dissolved A&#x003b2; (25-35), fibrillar A&#x003b2; (1-40) and oligomeric A&#x003b2; (1-40) on long-term potentiation (LTP) the cellular correlate for learning and memory <xref ref-type="bibr" rid="pone.0003236-Reymann1">&#x0005b;29&#x0005d;</xref> in acute hippocampal slices from rats and compared it with the influence on MTT activity. Surprisingly, in all tissue cultures we could not confirm the A&#x003b2; effects on MTT reduction known from primary cell cultures.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>A&#x003b2; impaired MTT reduction in neuronal, astroglia and microglia single cell cultures</title><p>We extensively investigated different A&#x003b2; species, namely freshly dissolved A&#x003b2; (25-35), fibrillar A&#x003b2; (1-40), oligomeric A&#x003b2; (1-40) and oligomeric A&#x003b2; (1-42) for their effects on MTT reduction in neuronal, astroglia and microglia single cell cultures, representing the majority of cell types within the brain. In accordance with the literature <xref ref-type="bibr" rid="pone.0003236-Liu1">&#x0005b;2&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Abe1">&#x0005b;10&#x0005d;</xref>, each A&#x003b2; species led to a pronounced diminution of MTT reduction in all cell types tested (Neurons: control 100&#x000b1;4.4&#x00025;, A&#x003b2; (25-35) 84.4&#x000b1;3.9&#x00025;, fibrillar A&#x003b2; (1-40) 61.1&#x000b1;3.5&#x00025;, oligomeric A&#x003b2; (1-40): 46.0&#x000b1;2.4&#x00025;, A&#x003b2; (1-42) 77.7&#x000b1;5.1&#x00025;; Microglia: control: 100&#x000b1;5.6&#x00025;, A&#x003b2; (25-35) 25.9&#x000b1;6.2&#x00025;, fibrillar A&#x003b2; (1-40) 42.3&#x000b1;6.5&#x00025;, oligomeric A&#x003b2; (1-40): 49.1&#x000b1;2.5&#x00025;, A&#x003b2; (1-42) 72.7&#x000b1;3.1&#x00025; <xref ref-type="fig" rid="pone-0003236-g001">Figure 1A</xref>). As we intended to investigate the effect of A&#x003b2; on MTT reduction in OHCs, where the most abundant cell type is astroglia, we determined the A&#x003b2; effect in detail in astroglia single cell cultures. Because OHCs and astroglial cultures are cultivated in different culture media we elucidated whether or not the A&#x003b2; mediated disruption of MTT reduction is influenced by the culture medium.</p><fig id="pone-0003236-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003236.g001</object-id><label>Figure 1</label><caption><title>Influence of A&#x003b2; on MTT reduction of single cell cultures.</title><p>A) Influence of A&#x003b2; on MTT reduction of neuron and microglia single cell cultures. When applied to cell cultures for 3 days, at 1 &#x000b5;M all A&#x003b2; species diminished the MTT reduction significantly in both cell types. The dashed line indicates the control level; &#x0002a;&#x0200a;&#x0003d;&#x0200a;p&#x02264;0.05, Mann&#x02013;Whitney U-test, n&#x0200a;&#x0003d;&#x0200a;10 per group B) Concentration dependent influence of A&#x003b2; on MTT reduction activity of astroglia single cell culture. When applied to cell culture for 3 days, any A&#x003b2; species diminished the MTT reduction significantly, compared to control. Congo red (2 &#x000b5;M) completely reverses the A&#x003b2; effect; A&#x003b2; (25-35) diminished the MTT reduction in NB medium, normally used for cultivation of OHC; the dashed line indicates the control level; &#x0002a;&#x0200a;&#x0003d;&#x0200a;p&#x02264;0.05, Mann&#x02013;Whitney U-test, n&#x0200a;&#x0003d;&#x0200a;10 per group C) Electron microscopic images (EMI) revealed that freshly dissolved A&#x003b2; (25-35) did not form aggregates. Moreover, EMI conformed the needle like structure of fibrillar A&#x003b2; (1-40) and the smaller, spherical shape of oligomeric A&#x003b2; (1-40) and oligomeric A&#x003b2; (1-42).</p></caption><graphic xlink:href="pone.0003236.g001"/></fig><p>All A&#x003b2; species tested acted in a dose dependent manner and A&#x003b2; (25-35) showed the highest activity (<xref ref-type="fig" rid="pone-0003236-g001">Figure 1B</xref>). In agreement with the literature <xref ref-type="bibr" rid="pone.0003236-Abe2">&#x0005b;30&#x0005d;</xref>, the A&#x003b2; effect could be blocked by congo red (<xref ref-type="fig" rid="pone-0003236-g001">Figure 1B</xref>). In neurobasal (NB) medium (used for OHC cultivation) the A&#x003b2; effect on MTT activity was similar to the results obtained with DMEM (used for single cell culture; 500 nM A&#x003b2; (25-35) in DMEM: 43.7&#x000b1;3.7&#x00025;, 500 nM A&#x003b2; (25-35) in NB: 39.4&#x000b1;2.2&#x00025;; values were normalized to control; <xref ref-type="fig" rid="pone-0003236-g001">Figure 1B</xref>).</p></sec><sec id="s2b"><title>A&#x003b2; (25-35), A&#x003b2; (1-40) and A&#x003b2; (1-42) failed to impair MTT reduction in OHC</title><p>Compared to single cells, the MTT reduction in OHCs was less frequently investigated. Therefore, we characterized the MTT assay in our system and examined its practicability to measure cell toxicity in OHCs. Similar to single cells, OHC produced the first formazane crystals immediately after MTT application and the reaction was saturated within 3 hours (<xref ref-type="fig" rid="pone-0003236-g002">Figure 2A</xref>). The MTT activity was diminished to 17.5&#x000b1;3.4&#x00025; by application of 15 mM glutamate (<xref ref-type="fig" rid="pone-0003236-g002">Figure 2B</xref>). Since this is an approved model for excitotoxicity related cell damage <xref ref-type="bibr" rid="pone.0003236-Noraberg1">&#x0005b;17&#x0005d;</xref>, we considered the MTT reduction assay to be suitable for the detection of cell damage in OHCs.</p><fig id="pone-0003236-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003236.g002</object-id><label>Figure 2</label><caption><title>Influence of A&#x003b2; on MTT reduction, PI uptake and GFAP expression of OHC.</title><p>A) Time dependent MTT reduction activity of OHC. Numbers indicate the time after MTT application in minutes B) Influence of glutamate, freshly dissolved A&#x003b2; (25-35), fibrillar A&#x003b2; (1-40) and oligomeric A&#x003b2; (1-42) on MTT reduction activity of OHC under different conditions. Application of 10 &#x000b5;M A&#x003b2; for 3&#x02013;6 days did not diminish the MTT reduction of OHC under different conditions; application of glutamate (15 &#x000b5;M) significantly reduced the MTT reduction, compared to control; the dashed line indicates the control level; &#x0002a;&#x0200a;&#x0003d;&#x0200a;p&#x02264;0.05, Mann&#x02013;Whitney U-test, n&#x02265;12 per group C) PI staining of A&#x003b2; and glutamate treated OHCs. Application of 10 &#x000b5;M freshly dissolved A&#x003b2; (25-35) and 10 &#x000b5;M fibrillar A&#x003b2; (1-40) into the medium for 3 days did not cause cell death. Application of glutamate (15 &#x000b5;M) induced cell death D) Immunostaining of cross sections against fibrillar A&#x003b2; (1-40) revealed the presence of A&#x003b2; in the slice E) GFAP and DAPI staining of oligomeric A&#x003b2; (1-42) treated and control slice. A&#x003b2; (1-42) caused an activation of astroglia within the OHC, indicated by an increased GFAP expression.</p></caption><graphic xlink:href="pone.0003236.g002"/></fig><p>As we intended to reproduce the A&#x003b2; effect from single cells in OHCs we applied high concentrations of freshly dissolved A&#x003b2; (25-35), fibrillar A&#x003b2; (1-40), oligomeric A&#x003b2; (1-40) and oligomeric A&#x003b2; (1-42). Surprisingly, no A&#x003b2; species caused an effect on MTT reduction, independent from the cell culture medium (A&#x003b2; (25-35) in NB: 93.4&#x000b1;22.1&#x00025;; in DMEM: 100.9&#x000b1;19.1&#x00025;; <xref ref-type="fig" rid="pone-0003236-g002">Figure 2B</xref>) and the kind of application (in the medium: A&#x003b2; (25-35) 93.4&#x000b1;22.1&#x00025;, fibrillar A&#x003b2; (1-40) 103.2&#x00025;&#x000b1;17.5&#x00025;, oligomeric A&#x003b2; (1-40) 103.4&#x00025;&#x000b1;22.6&#x00025; on top of the slice A&#x003b2; (25-35): 94.9&#x00025;&#x000b1;25.3&#x00025;; A&#x003b2; (1-42) 106.5&#x00025;&#x000b1;19.3&#x00025;); <xref ref-type="fig" rid="pone-0003236-g002">Figure 2B</xref>). Similar results were obtained for slices that were cultivated for a longer time period (20 DIV), ruling out the possibility that older and less viable slices are more susceptible to A&#x003b2; (aged OHCs: A&#x003b2; (25-35) 96.7&#x000b1;24.1&#x00025;, A&#x003b2; (1-40) 96.6&#x00025;&#x000b1;34.5&#x00025;; <xref ref-type="fig" rid="pone-0003236-g002">Figure 2B</xref>).</p><p>Succinate dehydrogenase activity <xref ref-type="bibr" rid="pone.0003236-Kimura1">&#x0005b;31&#x0005d;</xref> and exocytotic processes <xref ref-type="bibr" rid="pone.0003236-Gil1">&#x0005b;32&#x0005d;</xref> are temperature-dependent and exocytosis is influenced by osmotic forces <xref ref-type="bibr" rid="pone.0003236-Kachadorian1">&#x0005b;33&#x0005d;</xref>. In order to exclude that temperature and osmolarity modify the A&#x003b2; effect on MTT reduction in OHCs, we scrutinized the effect of these two parameters. However, lowering the ambient temperature to 21&#x000b0;C or 4&#x000b0;C generally caused a decreased MTT reduction activity of the slices (absolute values not shown), but did not elicit an A&#x003b2;-induced diminution in MTT reduction. In addition, the MTT reduction under hypotonic (280 mosmol&#x0002a;kg<sup>&#x02212;1</sup>-causes a cell swelling) and hypertonic (330 mosmol&#x0002a;kg<sup>&#x02212;1</sup>-causes a cell shrinkage) conditions was also not significantly altered (A&#x003b2; (25-35) hypertone medium 112.9&#x00025;&#x000b1;15.6&#x00025;, A&#x003b2; (25-35) hypotone medium 107.3&#x00025;&#x000b1;12.4&#x00025; of control; <xref ref-type="fig" rid="pone-0003236-g002">Figure 2B</xref>). Additionally, we confirmed the missing toxic effect of freshly dissolved A&#x003b2; (25-35) and fibrillar A&#x003b2; (1-40) in OHCs by an unchanged PI staining and by measuring the release of cytosolic enzyme lactate dehydrogenase (LDH) into the culture supernatant. There was no differences in the PI staining (<xref ref-type="fig" rid="pone-0003236-g002">Figure 2C</xref>) and the LDH release of A&#x003b2; (25-35) and fibrillar A&#x003b2; (1-40) treated slices, compared to control (LDH data not shown).</p><p>In order to rule out that diffusion problems due to the size of the A&#x003b2; aggregates impede toxicity in the OHCs, we immunostained cross sections of OHCs after A&#x003b2; (1-40) treatment. A&#x003b2; was clearly marked within the slice (<xref ref-type="fig" rid="pone-0003236-g002">Figure 2D</xref>). Furthermore and in line with the literature <xref ref-type="bibr" rid="pone.0003236-Xu1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Johansson1">&#x0005b;34&#x0005d;</xref>, A&#x003b2; (1-42) caused an activation of astroglia, as demonstrated by an increased expression of GFAP (<xref ref-type="fig" rid="pone-0003236-g002">Figure 2E</xref>). These results indicate that A&#x003b2; was able to affect the astroglia within the OHC, although A&#x003b2; failed to disturb the MTT reduction of the slice.</p></sec><sec id="s2c"><title>Separation of single cells from OHCs and treatment with A&#x003b2;</title><p>Considering our conflicting findings in single cells and OHCs it appeared likely that the susceptibility of cells to A&#x003b2; mediated diminution of MTT reduction activity depends on their environment. To address this matter, we split one OHC preparation into two groups. One group was cultivated further and the other group was separated into single cells. For the first time we prepared single cells from OHCs. Because of the matured state of the isolated cells only few neurons survived the isolation procedure and thus the cultures consisted largely of astrocytes (<xref ref-type="fig" rid="pone-0003236-g003">Figure 3</xref>).</p><fig id="pone-0003236-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003236.g003</object-id><label>Figure 3</label><caption><title>Influence of A&#x003b2; on MTT reduction activity of OHC and single cells, generated from OHC.</title><p>A) A&#x003b2; (25-35) 1 &#x000b5;M was applied to the slice for 3 days. The MTT assay was done 2 hours after the preparation of the single cells out of the slice. In this case, 1 &#x000b5;M A&#x003b2; did not diminish the MTT reduction of OHC and single cells; B) 1 &#x000b5;M A&#x003b2; was applied to the slices and single cells after the preparation for 2 days. In this case, A&#x003b2; (25-35) 1 &#x000b5;M significantly reduced the MTT reduction of single cells, compared to control; &#x0002a;&#x0200a;&#x0003d;&#x0200a;p&#x02264;0.05, Mann&#x02013;Whitney U-test, n&#x0200a;&#x0003d;&#x0200a;10 per group.</p></caption><graphic xlink:href="pone.0003236.g003"/></fig><p>When we exposed the slices to A&#x003b2; (25-35) before the separation and measured the MTT reduction activity two hours after the preparation, there was no effect of A&#x003b2; (25-35) on the MTT reduction of both, the slices and the single cells (<xref ref-type="fig" rid="pone-0003236-g003">Figure 3A</xref>). In contrast, when the slices were first separated and then A&#x003b2; (25-35) was applied to the two groups for 2 days, A&#x003b2; diminished the MTT reduction in single cell cultures but not in OHCs (A&#x003b2; (25-35) 80.1&#x00025;&#x000b1;1.0&#x00025; control: 100&#x00025;&#x000b1;1,1&#x00025;; <xref ref-type="fig" rid="pone-0003236-g003">Figure 3B</xref>).</p></sec><sec id="s2d"><title>A&#x003b2; related impairment of LTP is restricted to a particular A&#x003b2; species and does not correlate with MTT reduction in acute hippocampal slices</title><p>To further substantiate the assumption that cells within tissue-like structures react different to A&#x003b2; than single cells, we exposed acutely isolated hippocampal slices from adult rats to 500 nM A&#x003b2; (25-35) or 500 nM oligomeric A&#x003b2; (1-40) or 1 &#x000b5;M fibrillar A&#x003b2; (1-40) and measured the influence on LTP. When we exposed slices to A&#x003b2; (25-35) and oligomeric A&#x003b2; (1-40), 30 min before tetanus application, A&#x003b2; (25-35) did not influence the LTP, while application of oligomeric A&#x003b2; (1-40) significantly attenuated LTP (oligomeric A&#x003b2; (1-40): 139.5&#x00025;&#x000b1;11.3&#x00025; n&#x0200a;&#x0003d;&#x0200a;8; A&#x003b2; (25-35): 184.2&#x00025;&#x000b1;15.8&#x00025; n&#x0200a;&#x0003d;&#x0200a;8; control: 189.7&#x00025;&#x000b1;15.9&#x00025; n&#x0200a;&#x0003d;&#x0200a;16 of baseline value 240 min after tetanus application; <xref ref-type="fig" rid="pone-0003236-g004">Figure 4A</xref>). Because of their large molecule size A&#x003b2; (1-40) fibrils were expected to have limited and slow access to neuronal target structures. Therefore, we exposed slices to A&#x003b2; (1-40) fibrils persistently throughout the experiment and with a relatively high concentration of 1 &#x000b5;M. However, application of fibrillar A&#x003b2; (1-40) did not alter LTP (fibrillar A&#x003b2; (1-40): 187.1&#x000b1;16.6&#x00025;, n&#x0200a;&#x0003d;&#x0200a;8, of baseline value, 240 min after tetanus application; <xref ref-type="fig" rid="pone-0003236-g004">Figure 4A</xref>). To investigate whether the disturbed LTP caused by A&#x003b2; (1-40) oligomers correlates with a diminished MTT reduction, we applied MTT to acute slices in parallel to LTP recording. There was no difference in the MTT reduction between control, A&#x003b2; (25-35) and A&#x003b2; (1-40) oligomer treated slices (ACSF control: 100.0&#x000b1;25.0&#x00025;, A&#x003b2; (1-40) 107.9&#x00025;&#x000b1;27.0&#x00025;; A&#x003b2; (25-35) 106.7&#x00025;&#x000b1;15.7&#x00025; <xref ref-type="fig" rid="pone-0003236-g004">Figure 4B</xref>).</p><fig id="pone-0003236-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003236.g004</object-id><label>Figure 4</label><caption><title>Influence of A&#x003b2; on LTP and MTT reduction of acute isolated slices.</title><p>A) Influence of freshly dissolved A&#x003b2; (25-35), oligomeric A&#x003b2; (1-40) and fibrillar A&#x003b2; (1-40) on LTP of acute hippocampal slices. Oligomeric A&#x003b2; (1-40) significantly reduced the LTP, compared to control potentiation. Freshly dissolved A&#x003b2; (25-35) and fibrillar A&#x003b2; (1-40) did not effect the LTP; &#x0002a;&#x0200a;&#x0003d;&#x0200a;p&#x02264;0.05 ANOVA with repeated measures; The bar indicates the time of A&#x003b2; application. Tetanus was applied at time point 0; Analogue traces represent typical recordings of single experiments taken 20 minutes before tetanization (1), and 240 minutes after tetanization (2). B) A&#x003b2; treated acute slices did not differ from control slices in their MTT reduction activity. C) Influence of A&#x003b2; on MTT reduction activity of <italic>ex vivo</italic> slices. Injection of freshly dissolved A&#x003b2; (25-35) and oligomeric A&#x003b2; (1-42) for 3 days did not diminish the MTT reduction of the <italic>ex vivo</italic> slices, compared to untreated animals and the reverse control protein A&#x003b2; (35-25). D) Immunostaining of cross sections against A&#x003b2; revealed the presence of oligomeric A&#x003b2; (1-42) in the hippocampus.</p></caption><graphic xlink:href="pone.0003236.g004"/></fig></sec><sec id="s2e"><title>A&#x003b2; failed to diminish MTT reduction <italic>in vivo</italic></title><p>The short life span of acutely isolated slices from adult animals limits the exposure to A&#x003b2; aggregates. OHCs in contrast, allow long-time A&#x003b2; exposure but constitute of juvenile tissue. As we could not exclude that longer A&#x003b2; applications would indeed be able to reduce cellular viability in mature tissue we injected A&#x003b2; (25-35) and oligomeric A&#x003b2; (1-42) into the rat brain. Three days after A&#x003b2; application, the animals were sacrificed and we measured the MTT reduction in freshly prepared hippocampal slices. A&#x003b2; (25-35) and A&#x003b2; (1-42) did not influence the MTT reduction in this <italic>in vivo/ex vivo</italic> approach (untreated animal: 103.4&#x000b1;23.7&#x00025;, A&#x003b2; (35-25) control: 100.0&#x00025;&#x000b1;26.2&#x00025;, A&#x003b2; (1-42) 99.4&#x00025;&#x000b1;14.9&#x00025;; A&#x003b2; (25-35) 108.0&#x00025;&#x000b1;20.4&#x00025;; <xref ref-type="fig" rid="pone-0003236-g004">Figure 4C</xref>). To prove whether injected A&#x003b2; diffused into the hippocampus, we immunostained cross sections of the <italic>ex vivo</italic> slices. A&#x003b2; (1-42) oligomers were clearly marked within the slice (<xref ref-type="fig" rid="pone-0003236-g004">Figure 4D</xref>). Hence, an effect of A&#x003b2; on hippocampal cells could be expected. However, we could not observe a staining of A&#x003b2; (25-35), probably due to a wash out of that protein during the preparation procedure. But when injected A&#x003b2; (1-42) oligomers diffuse into the hippocampus, a successful diffusion of the smaller A&#x003b2; (25-35) peptide is likely. These data indicate that the missing A&#x003b2; effect on MTT reduction in OHC and acute isolated hippocampal slices represent the <italic>in vivo</italic> situation.</p></sec></sec><sec id="s3"><title>Discussion</title><p>In this study we compared the effect of different A&#x003b2; species on the MTT reduction activity in hippocampal neurons, astrocytes, microglia, OHCs, acutely isolated hippocampal slices from adult animals and the hippocampal formation <italic>in vivo</italic>. We showed that all tested A&#x003b2; species impaired MTT reduction activity in all single cell cultures already at high nanomolar concentrations. These findings are in good agreement with various other studies investigating toxic or activating A&#x003b2; effects in hippocampal neurons <xref ref-type="bibr" rid="pone.0003236-Ioudina1">&#x0005b;35&#x0005d;</xref>, astrocytes <xref ref-type="bibr" rid="pone.0003236-Abe1">&#x0005b;10&#x0005d;</xref> and microglia <xref ref-type="bibr" rid="pone.0003236-Korotzer1">&#x0005b;36&#x0005d;</xref>. In contrast to our findings in the single cell cultures none of the A&#x003b2; species affected cellular viability in OHCs, although we could confirm the presence of A&#x003b2; in the slices by immunostaining and GFAP upregulation. In line with our observations other studies in OHCs also showed no or, at very high concentrations, only very limited toxic effects of A&#x003b2; (25-35), A&#x003b2; (1-40) and A&#x003b2; (1-42) <xref ref-type="bibr" rid="pone.0003236-Imai1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Wang1">&#x0005b;19&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Baskys1">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Ito1">&#x0005b;38&#x0005d;</xref>. In contrast to that and to our findings Lambert et al. published in 1998 that slice cultures could be injured with as little as 5 nM soluble A&#x003b2; (1-42) of so called A&#x003b2; derived diffusible ligands (ADDL) <xref ref-type="bibr" rid="pone.0003236-Lambert1">&#x0005b;39&#x0005d;</xref>. Later, Chong et al. described in 2006 neuronal cell death in hippocampal brain slices because of A&#x003b2; (1-42) oligomer treatment <xref ref-type="bibr" rid="pone.0003236-Chong1">&#x0005b;40&#x0005d;</xref>. The reason for the difference to our results could be the kind of A&#x003b2; (1-42) preparation, as both groups used aggregation protocols which resulted in spheres of approximately similar size. However, their contrasting observations render it likely that their mode of preparation resulted in a different internal structure of the aggregates. Future studies should be carried out to extensively compare the different A&#x003b2; species for their potentially different effects. Nevertheless, we observed comparable detrimental effects of all investigated A&#x003b2; species on MTT reduction in single cell culture, which could not be seen in any complex tissue. That discrepancy between single cells and OHCs regarding the effect of A&#x003b2; is difficult to reconcile. As single cell cultures are almost exclusively prepared from embryonic tissue and as OHCs represent juvenile tissue one explanation could be that the respective cells are in different physiological states. Scrutinizing this assumption we show that single cells obtained from juvenile OHCs are only susceptible to A&#x003b2; effects after being cultured. Similarly, Yankner et al. (1990) reported that dissociated neurons maintained in cultures are resistant to A&#x003b2; (25-35) toxicity during the first days in culture and that A&#x003b2; neurotoxicity increases with the age of the culture <xref ref-type="bibr" rid="pone.0003236-Yankner1">&#x0005b;41&#x0005d;</xref>. This may indicate that cultured cells and cells that are embedded in the intact hippocampal synaptic circuitry and anatomy differ regarding cell properties which are crucial for A&#x003b2; toxicity or that the interaction between the neural elements in the relatively intact tissue enables a counteracting protective mechanism. Possible mechanisms may be alterations in the membrane lipid composition <xref ref-type="bibr" rid="pone.0003236-Lane1">&#x0005b;42&#x0005d;</xref> or an altered accessibility of lipid rafts for A&#x003b2; <xref ref-type="bibr" rid="pone.0003236-Williamson1">&#x0005b;43&#x0005d;</xref>. Similar reasons may account for the A&#x003b2; effects in studies where OHCs were cultured for several weeks <xref ref-type="bibr" rid="pone.0003236-Ishige1">&#x0005b;44&#x0005d;</xref>. These findings do not reflect the situation in adult tissue as we and others <xref ref-type="bibr" rid="pone.0003236-Podlisny1">&#x0005b;45&#x0005d;</xref> did not observe a fast toxic effect of A&#x003b2; after <italic>in vivo</italic> application. Also consistent with our results Geula et al. (1998) did not observe a significant A&#x003b2; toxicity in aged rats but found age-dependent A&#x003b2; toxicity in aged monkeys &#x0005b;46&#x0005d;. This does not exclude that the hippocampal neurons in OHCs, acutely isolated slices and <italic>in vivo</italic> are physiologically impaired, as LTP was disturbed in the acutely isolated slice preparations at least after A&#x003b2; oligomer application. Recent studies increasingly indicated that soluble, pre-fibrillar A&#x003b2; assemblies rather than mature fibrils may induce early neuronal alterations, leading to physiological interruption before cell death is detectable &#x0005b;47&#x0005d;. Our LTP experiments elucidated the effects of distinct A&#x003b2; species on synaptic potentiation. We show that A&#x003b2; (1-40) oligomers disturbed LTP, whereas A&#x003b2; (1-40) fibrils did not impair LTP, although A&#x003b2; (1-40) fibrils where higher concentrated and permanently exposed to the slices. This is in good agreement with the current view that A&#x003b2; oligomers are responsible for the early disturbance of brain physiology <xref ref-type="bibr" rid="pone.0003236-Cleary1">&#x0005b;48&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003236-Walsh3">&#x0005b;51&#x0005d;</xref>. Whether or not LTP disturbances are a first sign of neuronal degeneration remains to be elucidated. If so, the MTT assay would evidently be unable to detect such early alterations in cellular physiology, as we demonstrated that A&#x003b2; (1-40) oligomer mediated LTP disruption was not reflected by MTT reduction in slices. On the other hand, studies utilizing primary neuronal and astroglial cultures showed an inhibition of MTT reduction already 2 h after A&#x003b2; application <xref ref-type="bibr" rid="pone.0003236-Abe1">&#x0005b;10&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003236-Walsh4">&#x0005b;52&#x0005d;</xref>. This may not necessarily reflect cell death, as A&#x003b2;-induced alterations in MTT reduction in human cortical cultures could not be confirmed with other cytotoxicity assays like LDH and alamarBlue <xref ref-type="bibr" rid="pone.0003236-Wogulis1">&#x0005b;53&#x0005d;</xref>.</p><p>A&#x003b2; (25-35) did not affect LTP in the present study, although a diminution in LTP was found by others <xref ref-type="bibr" rid="pone.0003236-Lee1">&#x0005b;54&#x0005d;</xref>. One possible explanation for this discrepancy is the strain dependence of the A&#x003b2; (25-35) effect, as Gengler (2007) showed that the influence of A&#x003b2; (25-35) on LTP in rat depends on their genetic background <xref ref-type="bibr" rid="pone.0003236-Gengler1">&#x0005b;55&#x0005d;</xref>.</p><p>Taken together, we showed that single cell cultures are prone to impairment by A&#x003b2;, whereas cells embedded in the intact hippocampal synaptic circuitry and anatomy are quite resistant, suggesting that results obtained with cell cultures cannot be conferred directly to complex tissue. In addition, we demonstrated that A&#x003b2; mediated LTP disruption depends on the A&#x003b2; species and does not correlate with MTT reduction in acute isolated slices, relativizing the MTT assay as a reporter of early physiological disruption and drug testing. Thus, A&#x003b2; effects observed in single cell cultures should be interpreted cautiously regarding their relevance for more complex brain tissue, independently whether MTT reflects cellular viability or precedes cell death.</p></sec><sec sec-type="methods" id="s4"><title>Methods</title><sec id="s4a"><title>Single cell culture</title><p>The animals were maintained under constant environmental conditions, with an ambient temperature of 21&#x000b1;2&#x000b0;C, a relative humidity of 40&#x00025;, a 12-h light&#x02013;dark cycle and free access to food and water. All animal procedures have been approved by the ethics committee of the German federal state of Sachsen-Anhalt, and are in accordance with the European Communities Council Directive (86/609/EEC).</p><p>Cells cultures from 1-day-old Wistar rats (Institute breeding stock) were prepared and cultured as described previously <xref ref-type="bibr" rid="pone.0003236-Braun1">&#x0005b;56&#x0005d;</xref>. Briefly, newborn rats were decapitated, and the brains were removed and collected in ice-cold Hanks-buffer solution (Biochrom; Berlin, Germany). The brains were gently passed through nylon meshes of 250 mm and 136 mm pore width, in consecutive order. The cell suspension was centrifuged at 4&#x000b0;C for 5 min at 500g. The cells were resuspended in 10 ml growth medium (DMEM supplemented with 10&#x00025; (v&#x0002a;v<sup>&#x02212;1</sup>) fetal calf serum, 20 U&#x0002a;ml<sup>&#x02212;1</sup> penicillin and 20 mg&#x0002a;ml<sup>&#x02212;1</sup> streptomycin).</p><p>Single cells from OHCs were isolated by gently removing the slices from the membrane and collecting them in ice-cold Hanks-buffer solution (Biochrom; Berlin, Germany). Then the protocol for cell culture preparation described above was applied. Preparation and cultivation of OHCs was done as described below.</p><p>For astrocyte-enriched cultures (95&#x00025; astrocytes), cells were seeded in 48 well plates at a starting density of 2&#x0002a;10<sup>4</sup> cells/ml in DMEM supplemented with 10&#x00025; (v&#x0002a;v<sup>&#x02212;1</sup>) fetal calf serum and incubated at 37&#x000b0;C in an atmosphere containing 5&#x00025; CO<sub>2</sub>. The medium was changed every second day. For neuron-enriched culture (80&#x00025; neurones), the DMEM was exchanged by Start V Medium (Biochrom) 24 h after seeding.</p><p>The cell lineage BV2 microglia was cultured in DMEM supplemented with 10&#x00025; FBS, 1&#x00025; Pen/Strep (Biochrom), 1&#x00025; l-Glutamin (Biochrom) at a density not exceeding 5&#x0002a;10<sup>5</sup> cells&#x0002a;ml<sup>&#x02212;1</sup> and maintained in 5&#x00025; CO<sub>2</sub> at 37&#x000b0;C.</p></sec><sec id="s4b"><title>A&#x003b2; application/MTT assay</title><p>A&#x003b2; (25-35) (Bachem) was freshly dissolved in bidistilled water to a concentration of 1 mg&#x0002a;ml<sup>&#x02212;1</sup>. For fibril formation, recombinant A&#x003b2; (1-40) <xref ref-type="bibr" rid="pone.0003236-Christopeit1">&#x0005b;57&#x0005d;</xref> was dissolved in bidistilled water to a concentration of 1 mg&#x0002a;ml<sup>&#x02212;1</sup> and incubated for 5&#x02013;7 days at 37&#x000b0;C. The formation of fibrils was verified by negative stain electron microscopy. A&#x003b2; (1-42) oligomers were generated as described <xref ref-type="bibr" rid="pone.0003236-Barghorn1">&#x0005b;26&#x0005d;</xref>. The quality of the oligomer preparation was controlled by negative stain electron microscopy and Sodiumdodecylsulfate-Polyacrylamidgelelectrophoresis (SDS-PAGE). The A&#x003b2; species were added to the cell culture medium at a concentration of 0.5&#x02013;10 &#x000b5;M (A&#x003b2; (1-42) oligomers) or 0.5&#x02013;20 &#x000b5;M (A&#x003b2; (1-40) fibrils) and incubated for 1&#x02013;3 days. Then MTT (Carl Roth) was added to the medium (0.5 mg&#x0002a;ml<sup>&#x02212;1</sup>) and incubated for 3 hours. The medium was removed and the cells were diluted in 20&#x00025; SDS/50&#x00025; Dimethylformamid. The relative formazane concentration was measured by determination of the absorbance at 570 nm (well plate reader, Optima FluoStar).</p></sec><sec id="s4c"><title>Organotypic cultures</title><p>Organotypic hippocampal interface slice cultures from 10-day-old Wistar rats (Institute breeding stock) were prepared and cultured as interface slices as described previously <xref ref-type="bibr" rid="pone.0003236-Habicht1">&#x0005b;59&#x0005d;</xref>. Briefly, the slices were placed on membrane inserts in 6-well plates (NUNC, Wiesbaden, Germany) containing 1.2 ml of NB medium/well and were maintained in a humidified incubator for 12&#x02013;15 days <italic>in vitro</italic> (DIV).</p></sec><sec id="s4d"><title>Immunhistochemistry</title><p>For the immunohistochemical staining of A&#x003b2; and GFAP, the slices were fixed in 0.1 M phosphate buffer containing 4&#x00025; paraformaldehyde. The slices were stored in the fixative overnight. After cryoprotection in 30&#x00025; sucrose, the slices were rapidly frozen in methylbutane at &#x02212;80&#x000b0;C. The whole slices were cut on a sliding microtome and the 20 &#x000b5;m sections were stored at 4&#x000b0;C in cryoprotectant (CPS) containing 25&#x00025; ethylene glycol, 25&#x00025; glycerine in 0.1 M phosphate-buffered saline (PBS). The slices were transferred from CPS to 0.1 M phosphate buffer and washed overnight. Unspecific bindings were blocked for 2 h in the corresponding serum and then the slices were incubated with the primary antibodies and stored at 4&#x000b0;C overnight. All secondary antibodies were incubated at room temperature for 2 h. The slices were then coverslipped with 1,3-diethyl-8-phenylxanthine (DPX). The following primary antibodies and final dilutions were used: monoclonal mouse anti-GFAP (1&#x02236;200; Chemicon), polyclonal chicken anti-A&#x003b2; (1&#x02236;500; abcam), DAPI (1&#x02236;10000; MoBiTec). The primary antibodies were diluted in 0.1 M PBS/0.5&#x00025; Triton X-100 and 3&#x00025; donkey normal serum (Sigma, Deisenhofen, Germany). The following secondary antibodies and final dilutions were used: donkey anti-mouse Cy3 (1&#x02236;500; Dianova), donkey anti-chicken Cy2 (1&#x02236;100; Dianova). These secondary antibodies were diluted in 0.1 M PBS.</p></sec><sec id="s4e"><title>A&#x003b2; application/MTT assay/PI staining</title><p>The A&#x003b2; species were added to the slice culture medium at the respective concentrations (1&#x02013;10 &#x000b5;M) and incubated for 3&#x02013;6 days. For the application &#x0201c;on top of the slice&#x0201d;, 1 &#x000b5;l of the A&#x003b2; stock solution was directly applicated onto the surface of the slice. 1 &#x000b5;l of the solvent was applicated onto the control slices. Then MTT was applied to the medium (0,5 mg&#x0002a;ml<sup>&#x02212;1</sup>) and incubated for 3 hours. The slices were quickly removed from the membrane and completely diluted in 20&#x00025; SDS/50&#x00025; dimethylformamid (incubation for 24 h at RT). After centrifugation, the relative formazane concentration of the supernatant was measured by determination of the absorbance at 570 nm (well plate reader, Optima FluoStar).</p><p>Electron microscopy was done as previously described by <xref ref-type="bibr" rid="pone.0003236-Schroder1">&#x0005b;60&#x0005d;</xref>.</p><p>Cell death was evaluated by cellular incorporation of propidium iodide (PI) 3d and 6d after A&#x003b2; treatment. Cultures were incubated with PI-containing medium (10 &#x000b5;M) for 2 h at 33&#x000b0;C. Fluorescent images were acquired semiautomatized (Nikon motorized stage; LUCIA software) and analyzed by densitometry to quantify necrotic cell death (LUCIA Image analysis software).</p></sec><sec id="s4f"><title>Acute hippocampal slices/LTP</title><p>Hippocampal slices (400 &#x000b5;m thick) were prepared from 7- to 8-week-old male Wistar rats (Institute breeding stock) as described previously <xref ref-type="bibr" rid="pone.0003236-Baldauf1">&#x0005b;61&#x0005d;</xref>. Briefly, both hippocampi were isolated and transferred into a submerged-type recording chamber where they were allowed to recover for at least 1 h before the experiment started. The chamber was constantly perfused with artificial cerebrospinal fluid (ACSF) at a rate of 2.5 ml/min at 33&#x000b1;1&#x000b0;C.</p><p>Synaptic responses were elicited by stimulation of the Schaffer collateral&#x02013;commissural fibers in the stratum radiatum of the CA1 region using lacquer-coated stainless steel stimulating electrodes. Glass electrodes (filled with ACSF, 1&#x02013;4 M&#x003a9;) were placed in the apical dendritic layer to record field excitatory postsynaptic potentials (fEPSPs). The initial slope of the fEPSP was used as a measure of this potential. The stimulus strength of the test pulses was adjusted to 30&#x00025; of the EPSP maximum. During baseline recording, single stimuli were applied every minute (0,0166 Hz) and were averaged every 5 min. Once a stable baseline had been established, long-term potentiation was induced by applying 100 pulses at an interval of 10 ms and a width of the single pulses of 0.2 ms (strong tetanus) three times at 10 min intervals.</p><p>A&#x003b2; (1-40) oligomers and fibrils were prepared as described previously <xref ref-type="bibr" rid="pone.0003236-Kayed1">&#x0005b;27&#x0005d;</xref> and visualized by negative stain electron microscopy. Immediately after the slice preparation, fibrillar A&#x003b2; (1-40) was persistently applied to the slices at a concentration of 1 &#x000b5;M. A&#x003b2; (1-40) oligomers and A&#x003b2; (25-35) were applied to the slice for 30 min before tetanus application at a concentration of 500 nM. The A&#x003b2; (1-40) solvent HFIP was removed from the ACSF by exposure to a gentle stream of carbogen for 1h. For control experiments we added the same amount of HFIP used for the A&#x003b2; (1-40) experiment to the ACSF and removed it by gasification. There was no difference between the potentiation in the HFIP-deprived ACSF and pure ACSF and, therefore, these experiments were pooled. In parallel to the experiments, some slices of the same preparation were separately exposed to A&#x003b2; for 3&#x02013;4 hours and analyzed with MTT assay as described above.</p></sec><sec id="s4g"><title>In vivo infusion of A&#x003b2;</title><p><italic>In vivo</italic> infusion was performed as described previously <xref ref-type="bibr" rid="pone.0003236-Paxinos1">&#x0005b;62&#x0005d;</xref>. Briefly, anaesthesia of 10-week-old male Wistar rats (Institute breeding stock) was induced with halothane in a mixture of nitrous oxide and oxygen (50&#x02236;50) and maintained with 2&#x02013;3&#x00025; halothane (Sigma, Deisenhofen, Germany) via a rat anaesthetic mask (St&#x000f6;lting). The animals were placed in a Kopf stereotaxic frame. Following a midline incision, a burr hole (1 mm in diameter) was drilled into the skull (coordinates: posterior, 0.9 mm from bregma; lateral, 1.7 mm to satura sagittalis) and a 29-gauge cannula was lowered to 4.5 mm below the skull, according to the rat brain atlas of Paxinos and Watson &#x0005b;63&#x0005d;. A&#x003b2; (25-35) (1 mg&#x0002a;ml<sup>&#x02212;1</sup>) or A&#x003b2; (1-42) oligomer (1 mg&#x0002a;ml<sup>&#x02212;1</sup>) was injected intracerebroventricularly in 3-&#x000b5;l sterile solvent over 5 min. After 5 min the cannula was slowly withdrawn. A&#x003b2; (35-25) (1 mg&#x0002a;ml<sup>&#x02212;1</sup>) was used as inactive peptide control. After three days, acute hippocampal slices were prepared as described above, then directly placed on cell culture membranes and the MTT reduction activity analyzed as described above.</p></sec><sec id="s4h"><title>Statistics</title><p>Values of LTP recording are given as mean&#x000b1;S.E.M. Values of MTT reduction are given as mean&#x000b1;S.D. As indicated in <xref ref-type="sec" rid="s2">Results</xref>, the Mann&#x02013;Whitney U-test or the analysis of variance (ANOVA) with repeated measures was used to compare the field potentials between two groups of differentially treated cells or slices, respectively (i.e., control vs. A&#x003b2; treatment), where appropriate.</p></sec></sec></body><back><ack><p>The authors wish to thank Katrin B&#x000f6;hm for expert technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0003236-Walsh1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Selkoe</surname><given-names>DJ</given-names></name></person-group><year>2007</year><article-title>A beta oligomers - a decade of discovery.</article-title><source>J Neurochem</source><volume>101</volume><fpage>1172</fpage><lpage>1184</lpage><pub-id pub-id-type="pmid">17286590</pub-id></citation></ref><ref id="pone.0003236-Liu1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><year>1999</year><article-title>Understanding the biological activity of amyloid proteins in vitro: from inhibited cellular MTT reduction to altered cellular cholesterol homeostatis.</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><volume>23</volume><fpage>377</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">10378224</pub-id></citation></ref><ref id="pone.0003236-Hayon1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hayon</surname><given-names>T</given-names></name><name><surname>Dvilansky</surname><given-names>A</given-names></name><name><surname>Shpilberg</surname><given-names>O</given-names></name><name><surname>Nathan</surname><given-names>I</given-names></name></person-group><year>2003</year><article-title>Appraisal of the MTT-based assay as a useful tool for predicting drug chemosensitivity in leukemia.</article-title><source>Leuk Lymphoma</source><volume>44</volume><fpage>1957</fpage><lpage>1962</lpage><pub-id pub-id-type="pmid">14738150</pub-id></citation></ref><ref id="pone.0003236-Latini1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Latini</surname><given-names>A</given-names></name><name><surname>da Silva</surname><given-names>CG</given-names></name><name><surname>Ferreira</surname><given-names>GC</given-names></name><name><surname>Schuck</surname><given-names>PF</given-names></name><name><surname>Scussiato</surname><given-names>K</given-names></name><etal/></person-group><year>2005</year><article-title>Mitochondrial energy metabolism is markedly impaired by D-2-hydroxyglutaric acid in rat tissues.</article-title><source>Mol Genet Metab</source><volume>86</volume><fpage>188</fpage><lpage>199</lpage><pub-id pub-id-type="pmid">15963747</pub-id></citation></ref><ref id="pone.0003236-Lushnikova1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lushnikova</surname><given-names>IV</given-names></name><name><surname>Voronin</surname><given-names>KY</given-names></name><name><surname>Malyarevskyy</surname><given-names>PY</given-names></name><name><surname>Skibo</surname><given-names>GG</given-names></name></person-group><year>2004</year><article-title>Morphological and functional changes in rat hippocampal slice cultures after short-term oxygen-glucose deprivation.</article-title><source>J Cell Mol Med</source><volume>8</volume><fpage>241</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">15256072</pub-id></citation></ref><ref id="pone.0003236-Liu2"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>ML</given-names></name><name><surname>Hong</surname><given-names>ST</given-names></name></person-group><year>2005</year><article-title>Early phase of amyloid beta42-induced cytotoxicity in neuronal cells is associated with vacuole formation and enhancement of exocytosis.</article-title><source>Exp Mol Med</source><volume>37</volume><fpage>559</fpage><lpage>566</lpage><pub-id pub-id-type="pmid">16391517</pub-id></citation></ref><ref id="pone.0003236-Shearman1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shearman</surname><given-names>MS</given-names></name><name><surname>Ragan</surname><given-names>CI</given-names></name><name><surname>Iversen</surname><given-names>LL</given-names></name></person-group><year>1994</year><article-title>Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.</article-title><source>Proc Natl Acad Sci U S A</source><volume>91</volume><fpage>1470</fpage><lpage>1474</lpage><pub-id pub-id-type="pmid">8108433</pub-id></citation></ref><ref id="pone.0003236-Kaneko1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname><given-names>I</given-names></name><name><surname>Yamada</surname><given-names>N</given-names></name><name><surname>Sakuraba</surname><given-names>Y</given-names></name><name><surname>Kamenosono</surname><given-names>M</given-names></name><name><surname>Tutumi</surname><given-names>S</given-names></name></person-group><year>1995</year><article-title>Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue.</article-title><source>J Neurochem</source><volume>65</volume><fpage>2585</fpage><lpage>2593</lpage><pub-id pub-id-type="pmid">7595555</pub-id></citation></ref><ref id="pone.0003236-Liu3"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Schubert</surname><given-names>D</given-names></name></person-group><year>1997</year><article-title>Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis.</article-title><source>J Neurochem</source><volume>69</volume><fpage>2285</fpage><lpage>2293</lpage><pub-id pub-id-type="pmid">9375659</pub-id></citation></ref><ref id="pone.0003236-Abe1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name></person-group><year>1998</year><article-title>Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes.</article-title><source>Neurosci Res</source><volume>31</volume><fpage>295</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">9809588</pub-id></citation></ref><ref id="pone.0003236-Bieschke1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bieschke</surname><given-names>J</given-names></name><name><surname>Siegel</surname><given-names>SJ</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Kelly</surname><given-names>JW</given-names></name></person-group><year>2008</year><article-title>Alzheimer's Abeta Peptides Containing an Isostructural Backbone Mutation Afford Distinct Aggregate Morphologies but Analogous Cytotoxicity. Evidence for a Common Low-Abundance Toxic Structure(s)?</article-title><source>Biochemistry</source><volume>47</volume><fpage>50</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">18078350</pub-id></citation></ref><ref id="pone.0003236-Boutaud1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boutaud</surname><given-names>O</given-names></name><name><surname>Montine</surname><given-names>TJ</given-names></name><name><surname>Chang</surname><given-names>L</given-names></name><name><surname>Klein</surname><given-names>WL</given-names></name><name><surname>Oates</surname><given-names>JA</given-names></name></person-group><year>2006</year><article-title>PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.</article-title><source>J Neurochem</source><volume>96</volume><fpage>917</fpage><lpage>923</lpage><pub-id pub-id-type="pmid">16412101</pub-id></citation></ref><ref id="pone.0003236-Choi1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>MJ</given-names></name><name><surname>Heo</surname><given-names>HJ</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Hong</surname><given-names>B</given-names></name><etal/></person-group><year>2006</year><article-title>Protective effect of Rosa laevigata against amyloid beta peptide-induced oxidative stress.</article-title><source>Amyloid</source><volume>13</volume><fpage>6</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16690494</pub-id></citation></ref><ref id="pone.0003236-Szegedi1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szegedi</surname><given-names>V</given-names></name><name><surname>Juhasz</surname><given-names>G</given-names></name><name><surname>Rozsa</surname><given-names>E</given-names></name><name><surname>Juhasz-Vedres</surname><given-names>G</given-names></name><name><surname>Datki</surname><given-names>Z</given-names></name><etal/></person-group><year>2006</year><article-title>Endomorphin-2, an endogenous tetrapeptide, protects against Abeta1-42 in vitro and in vivo.</article-title><source>FASEB J</source><volume>20</volume><fpage>1191</fpage><lpage>1193</lpage><pub-id pub-id-type="pmid">16636106</pub-id></citation></ref><ref id="pone.0003236-Sundstrom1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundstrom</surname><given-names>L</given-names></name><name><surname>Morrison</surname><given-names>B</given-names></name><name><surname>Bradley</surname><given-names>M</given-names></name><name><surname>Pringle</surname><given-names>A</given-names></name></person-group><year>2005</year><article-title>Organotypic cultures as tools for functional screening in the CNS.</article-title><source>Drug Discov Today</source><volume>10</volume><fpage>993</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">16023058</pub-id></citation></ref><ref id="pone.0003236-Neumann1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neumann</surname><given-names>J</given-names></name><name><surname>Gunzer</surname><given-names>M</given-names></name><name><surname>Gutzeit</surname><given-names>HO</given-names></name><name><surname>Ullrich</surname><given-names>O</given-names></name><name><surname>Reymann</surname><given-names>KG</given-names></name><etal/></person-group><year>2006</year><article-title>Microglia provide neuroprotection after ischemia.</article-title><source>FASEB J</source><volume>20</volume><fpage>714</fpage><lpage>716</lpage><pub-id pub-id-type="pmid">16473887</pub-id></citation></ref><ref id="pone.0003236-Noraberg1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noraberg</surname><given-names>J</given-names></name><name><surname>Poulsen</surname><given-names>FR</given-names></name><name><surname>Blaabjerg</surname><given-names>M</given-names></name><name><surname>Kristensen</surname><given-names>BW</given-names></name><name><surname>Bonde</surname><given-names>C</given-names></name><etal/></person-group><year>2005</year><article-title>Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair.</article-title><source>Curr Drug Targets CNS Neurol Disord</source><volume>4</volume><fpage>435</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">16101559</pub-id></citation></ref><ref id="pone.0003236-Imai1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Kosuge</surname><given-names>Y</given-names></name><name><surname>Ishige</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name></person-group><year>2007</year><article-title>Amyloid beta-protein potentiates tunicamycin-induced neuronal death in organotypic hippocampal slice cultures.</article-title><source>Neuroscience</source><volume>147</volume><fpage>639</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">17560726</pub-id></citation></ref><ref id="pone.0003236-Wang1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Takata</surname><given-names>T</given-names></name><name><surname>Sakurai</surname><given-names>T</given-names></name><name><surname>Yokono</surname><given-names>K</given-names></name></person-group><year>2007</year><article-title>Different effects of monocarboxylates on neuronal survival and beta-amyloid toxicity.</article-title><source>Eur J Neurosci</source><volume>26</volume><fpage>2142</fpage><lpage>2150</lpage><pub-id pub-id-type="pmid">17908170</pub-id></citation></ref><ref id="pone.0003236-Xu1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Malouf</surname><given-names>AT</given-names></name><name><surname>Messing</surname><given-names>A</given-names></name><name><surname>Silver</surname><given-names>J</given-names></name></person-group><year>1999</year><article-title>Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid.</article-title><source>Glia</source><volume>25</volume><fpage>390</fpage><lpage>403</lpage><pub-id pub-id-type="pmid">10028921</pub-id></citation></ref><ref id="pone.0003236-Shankar1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shankar</surname><given-names>GM</given-names></name><name><surname>Bloodgood</surname><given-names>BL</given-names></name><name><surname>Townsend</surname><given-names>M</given-names></name><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Selkoe</surname><given-names>DJ</given-names></name><etal/></person-group><year>2007</year><article-title>Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.</article-title><source>J Neurosci</source><volume>27</volume><fpage>2866</fpage><lpage>2875</lpage><pub-id pub-id-type="pmid">17360908</pub-id></citation></ref><ref id="pone.0003236-Connelly1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Connelly</surname><given-names>CA</given-names></name><name><surname>Chen</surname><given-names>LC</given-names></name><name><surname>Colquhoun</surname><given-names>SD</given-names></name></person-group><year>2000</year><article-title>Metabolic activity of cultured rat brainstem, hippocampal and spinal cord slices.</article-title><source>J Neurosci Methods</source><volume>99</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10936637</pub-id></citation></ref><ref id="pone.0003236-Holscher1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holscher</surname><given-names>C</given-names></name><name><surname>Gengler</surname><given-names>S</given-names></name><name><surname>Gault</surname><given-names>VA</given-names></name><name><surname>Harriott</surname><given-names>P</given-names></name><name><surname>Mallot</surname><given-names>HA</given-names></name></person-group><year>2007</year><article-title>Soluble beta-amyloid&#x0005b;25-35&#x0005d; reversibly impairs hippocampal synaptic plasticity and spatial learning.</article-title><source>Eur J Pharmacol</source><volume>561</volume><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">17320856</pub-id></citation></ref><ref id="pone.0003236-Kato1"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name></person-group><year>1997</year><article-title>Nanomolar amyloid beta protein-induced inhibition of cellular redox activity in cultured astrocytes.</article-title><source>J Neurochem</source><volume>68</volume><fpage>1889</fpage><lpage>1895</lpage><pub-id pub-id-type="pmid">9109514</pub-id></citation></ref><ref id="pone.0003236-Fandrich1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fandrich</surname><given-names>M</given-names></name></person-group><year>2007</year><article-title>On the structural definition of amyloid fibrils and other polypeptide aggregates.</article-title><source>Cell Mol Life Sci</source><volume>64</volume><fpage>2066</fpage><lpage>2078</lpage><pub-id pub-id-type="pmid">17530168</pub-id></citation></ref><ref id="pone.0003236-Barghorn1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barghorn</surname><given-names>S</given-names></name><name><surname>Nimmrich</surname><given-names>V</given-names></name><name><surname>Striebinger</surname><given-names>A</given-names></name><name><surname>Krantz</surname><given-names>C</given-names></name><name><surname>Keller</surname><given-names>P</given-names></name><etal/></person-group><year>2005</year><article-title>Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.</article-title><source>J Neurochem</source><volume>95</volume><fpage>834</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">16135089</pub-id></citation></ref><ref id="pone.0003236-Kayed1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Head</surname><given-names>E</given-names></name><name><surname>Thompson</surname><given-names>JL</given-names></name><name><surname>McIntire</surname><given-names>TM</given-names></name><name><surname>Milton</surname><given-names>SC</given-names></name><etal/></person-group><year>2003</year><article-title>Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.</article-title><source>Science</source><volume>300</volume><fpage>486</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">12702875</pub-id></citation></ref><ref id="pone.0003236-Rowan1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rowan</surname><given-names>MJ</given-names></name><name><surname>Klyubin</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Hu</surname><given-names>NW</given-names></name><name><surname>Anwyl</surname><given-names>R</given-names></name></person-group><year>2007</year><article-title>Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.</article-title><source>Biochem Soc Trans</source><volume>35</volume><fpage>1219</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">17956317</pub-id></citation></ref><ref id="pone.0003236-Reymann1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reymann</surname><given-names>KG</given-names></name><name><surname>Frey</surname><given-names>JU</given-names></name></person-group><year>2007</year><article-title>The late maintenance of hippocampal LTP: requirements, phases, &#x02018;synaptic tagging&#x02019;, &#x02018;late-associativity&#x02019; and implications.</article-title><source>Neuropharmacology</source><volume>52</volume><fpage>24</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">16919684</pub-id></citation></ref><ref id="pone.0003236-Abe2"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname><given-names>K</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name></person-group><year>1997</year><article-title>Congo red reverses amyloid beta protein-induced cellular stress in astrocytes.</article-title><source>Neurosci Res</source><volume>29</volume><fpage>129</fpage><lpage>134</lpage><pub-id pub-id-type="pmid">9359461</pub-id></citation></ref><ref id="pone.0003236-Kimura1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Hauber</surname><given-names>J</given-names></name><name><surname>Singer</surname><given-names>TP</given-names></name></person-group><year>1967</year><article-title>Studies on succinate dehydrogenase. 13. Reversible activation of the mammalian enzyme.</article-title><source>J Biol Chem</source><volume>242</volume><fpage>4987</fpage><lpage>4993</lpage><pub-id pub-id-type="pmid">6058941</pub-id></citation></ref><ref id="pone.0003236-Gil1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>A</given-names></name><name><surname>Viniegra</surname><given-names>S</given-names></name><name><surname>Gutierrez</surname><given-names>LM</given-names></name></person-group><year>2001</year><article-title>Temperature and PMA affect different phases of exocytosis in bovine chromaffin cells.</article-title><source>Eur J Neurosci</source><volume>13</volume><fpage>1380</fpage><lpage>1386</lpage><pub-id pub-id-type="pmid">11298798</pub-id></citation></ref><ref id="pone.0003236-Kachadorian1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kachadorian</surname><given-names>WA</given-names></name><name><surname>Muller</surname><given-names>J</given-names></name><name><surname>Finkelstein</surname><given-names>A</given-names></name></person-group><year>1981</year><article-title>Role of osmotic forces in exocytosis: studies of ADH-induced fusion in toad urinary bladder.</article-title><source>J Cell Biol</source><volume>91</volume><fpage>584</fpage><lpage>588</lpage><pub-id pub-id-type="pmid">6796595</pub-id></citation></ref><ref id="pone.0003236-Johansson1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>S</given-names></name><name><surname>Radesater</surname><given-names>AC</given-names></name><name><surname>Cowburn</surname><given-names>RF</given-names></name><name><surname>Thyberg</surname><given-names>J</given-names></name><name><surname>Luthman</surname><given-names>J</given-names></name></person-group><year>2006</year><article-title>Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats.</article-title><source>Exp Brain Res</source><volume>168</volume><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">16175362</pub-id></citation></ref><ref id="pone.0003236-Ioudina1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ioudina</surname><given-names>M</given-names></name><name><surname>Uemura</surname><given-names>E</given-names></name></person-group><year>2003</year><article-title>A three amino acid peptide, Gly-Pro-Arg, protects and rescues cell death induced by amyloid beta-peptide.</article-title><source>Exp Neurol</source><volume>184</volume><fpage>923</fpage><lpage>929</lpage><pub-id pub-id-type="pmid">14769384</pub-id></citation></ref><ref id="pone.0003236-Korotzer1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Korotzer</surname><given-names>AR</given-names></name><name><surname>Whittemore</surname><given-names>ER</given-names></name><name><surname>Cotman</surname><given-names>CW</given-names></name></person-group><year>1995</year><article-title>Differential regulation by beta-amyloid peptides of intracellular free Ca2&#x0002b; concentration in cultured rat microglia.</article-title><source>Eur J Pharmacol</source><volume>288</volume><fpage>125</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">7720773</pub-id></citation></ref><ref id="pone.0003236-Baskys1"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baskys</surname><given-names>A</given-names></name><name><surname>Adamchik</surname><given-names>Y</given-names></name></person-group><year>2001</year><article-title>Neuroprotective effects of extracellular glutamate are absent in hippocampal organotypic cultures treated with the amyloid peptide Abeta(25-35).</article-title><source>Brain Res</source><volume>907</volume><fpage>188</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">11430902</pub-id></citation></ref><ref id="pone.0003236-Ito1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Takagi</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Ishige</surname><given-names>K</given-names></name></person-group><year>2003</year><article-title>Neurotoxicity induced by amyloid beta-peptide and ibotenic acid in organotypic hippocampal cultures: protection by S-allyl-L-cysteine, a garlic compound.</article-title><source>Brain Res</source><volume>19</volume><volume>985</volume><fpage>98</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">12957372</pub-id></citation></ref><ref id="pone.0003236-Lambert1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>MP</given-names></name><name><surname>Barlow</surname><given-names>AK</given-names></name><name><surname>Chromy</surname><given-names>BA</given-names></name><name><surname>Edwards</surname><given-names>C</given-names></name><name><surname>Freed</surname><given-names>R</given-names></name><etal/></person-group><year>1998</year><article-title>Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.</article-title><source>Proc Natl Acad Sci U S A</source><volume>95</volume><fpage>6448</fpage><lpage>6453</lpage><pub-id pub-id-type="pmid">9600986</pub-id></citation></ref><ref id="pone.0003236-Chong1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>YH</given-names></name><name><surname>Shin</surname><given-names>YJ</given-names></name><name><surname>Lee</surname><given-names>EO</given-names></name><name><surname>Kayed</surname><given-names>R</given-names></name><name><surname>Glabe</surname><given-names>CG</given-names></name><etal/></person-group><year>2006</year><article-title>ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>20315</fpage><lpage>20325</lpage><pub-id pub-id-type="pmid">16714296</pub-id></citation></ref><ref id="pone.0003236-Yankner1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yankner</surname><given-names>BA</given-names></name><name><surname>Duffy</surname><given-names>LK</given-names></name><name><surname>Kirschner</surname><given-names>DA</given-names></name></person-group><year>1990</year><article-title>Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.</article-title><source>Science</source><volume>250</volume><fpage>279</fpage><lpage>282</lpage><pub-id pub-id-type="pmid">2218531</pub-id></citation></ref><ref id="pone.0003236-Lane1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>RM</given-names></name><name><surname>Farlow</surname><given-names>MR</given-names></name></person-group><year>2005</year><article-title>Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease.</article-title><source>J Lipid Res</source><volume>46</volume><fpage>949</fpage><lpage>968</lpage><pub-id pub-id-type="pmid">15716586</pub-id></citation></ref><ref id="pone.0003236-Williamson1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williamson</surname><given-names>R</given-names></name><name><surname>Usardi</surname><given-names>A</given-names></name><name><surname>Hanger</surname><given-names>DP</given-names></name><name><surname>Anderton</surname><given-names>BH</given-names></name></person-group><year>2007</year><article-title>Membrane-bound {beta}-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism.</article-title><source>FASEB J</source></citation></ref><ref id="pone.0003236-Ishige1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishige</surname><given-names>K</given-names></name><name><surname>Takagi</surname><given-names>N</given-names></name><name><surname>Imai</surname><given-names>T</given-names></name><name><surname>Rausch</surname><given-names>WD</given-names></name><name><surname>Kosuge</surname><given-names>Y</given-names></name><etal/></person-group><year>2007</year><article-title>Role of caspase-12 in amyloid beta-peptide-induced toxicity in organotypic hippocampal slices cultured for long periods.</article-title><source>J Pharmacol Sci</source><volume>104</volume><fpage>46</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">17452809</pub-id></citation></ref><ref id="pone.0003236-Podlisny1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Podlisny</surname><given-names>MB</given-names></name><name><surname>Stephenson</surname><given-names>DT</given-names></name><name><surname>Frosch</surname><given-names>MP</given-names></name><name><surname>Tolan</surname><given-names>DR</given-names></name><name><surname>Lieberburg</surname><given-names>I</given-names></name><etal/></person-group><year>1993</year><article-title>Microinjection of synthetic amyloid beta-protein in monkey cerebral cortex fails to produce acute neurotoxicity.</article-title><source>Am J Pathol</source><volume>142</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">8424453</pub-id></citation></ref><ref id="pone.0003236-Geula1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geula</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>CK</given-names></name><name><surname>Saroff</surname><given-names>D</given-names></name><name><surname>Lorenzo</surname><given-names>A</given-names></name><name><surname>Yuan</surname><given-names>M</given-names></name><etal/></person-group><year>1998</year><article-title>Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity.</article-title><source>Nat Med</source><volume>4(7)</volume><fpage>827</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">9662375</pub-id></citation></ref><ref id="pone.0003236-Walsh2"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Klyubin</surname><given-names>I</given-names></name><name><surname>Fadeeva</surname><given-names>JV</given-names></name><name><surname>Rowan</surname><given-names>MJ</given-names></name><name><surname>Selkoe</surname><given-names>DJ</given-names></name></person-group><year>2002</year><article-title>Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.</article-title><source>Biochem Soc Trans</source><volume>30</volume><fpage>552</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">12196135</pub-id></citation></ref><ref id="pone.0003236-Cleary1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cleary</surname><given-names>JP</given-names></name><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Hofmeister</surname><given-names>JJ</given-names></name><name><surname>Shankar</surname><given-names>GM</given-names></name><name><surname>Kuskowski</surname><given-names>MA</given-names></name><etal/></person-group><year>2005</year><article-title>Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function.</article-title><source>Nat Neurosci</source><volume>8</volume><fpage>79</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">15608634</pub-id></citation></ref><ref id="pone.0003236-Glabe1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glabe</surname><given-names>CG</given-names></name></person-group><year>2006</year><article-title>Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.</article-title><source>Neurobiol Aging</source><volume>27</volume><fpage>570</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">16481071</pub-id></citation></ref><ref id="pone.0003236-Viola1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Viola</surname><given-names>KL</given-names></name><name><surname>Velasco</surname><given-names>PT</given-names></name><name><surname>Klein</surname><given-names>WL</given-names></name></person-group><year>2008</year><article-title>Why Alzheimer's Is a Disease of Memory: The Attack on Synapses by A beta Oligomers (ADDLs).</article-title><source>J Nutr Health Aging</source><volume>12</volume><fpage>51S</fpage><lpage>57S</lpage><pub-id pub-id-type="pmid">18165846</pub-id></citation></ref><ref id="pone.0003236-Walsh3"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Klyubin</surname><given-names>I</given-names></name><name><surname>Shankar</surname><given-names>GM</given-names></name><name><surname>Townsend</surname><given-names>M</given-names></name><name><surname>Fadeeva</surname><given-names>JV</given-names></name><etal/></person-group><year>2005</year><article-title>The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.</article-title><source>Biochem Soc Trans</source><volume>33</volume><fpage>1087</fpage><lpage>1090</lpage><pub-id pub-id-type="pmid">16246051</pub-id></citation></ref><ref id="pone.0003236-Walsh4"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>DM</given-names></name><name><surname>Hartley</surname><given-names>DM</given-names></name><name><surname>Kusumoto</surname><given-names>Y</given-names></name><name><surname>Fezoui</surname><given-names>Y</given-names></name><name><surname>Condron</surname><given-names>MM</given-names></name><etal/></person-group><year>1999</year><article-title>Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>25945</fpage><lpage>25952</lpage><pub-id pub-id-type="pmid">10464339</pub-id></citation></ref><ref id="pone.0003236-Wogulis1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wogulis</surname><given-names>M</given-names></name><name><surname>Wright</surname><given-names>S</given-names></name><name><surname>Cunningham</surname><given-names>D</given-names></name><name><surname>Chilcote</surname><given-names>T</given-names></name><name><surname>Powell</surname><given-names>K</given-names></name><etal/></person-group><year>2005</year><article-title>Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death.</article-title><source>J Neurosci</source><volume>25</volume><fpage>1071</fpage><lpage>1080</lpage><pub-id pub-id-type="pmid">15689542</pub-id></citation></ref><ref id="pone.0003236-Lee1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>CC</given-names></name><name><surname>Kuo</surname><given-names>YM</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Hsu</surname><given-names>KS</given-names></name></person-group><year>2007</year><article-title>Insulin rescues amyloid beta-induced impairment of hippocampal long-term potentiation.</article-title><source>Neurobiol Aging</source></citation></ref><ref id="pone.0003236-Gengler1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gengler</surname><given-names>S</given-names></name><name><surname>Gault</surname><given-names>VA</given-names></name><name><surname>Harriott</surname><given-names>P</given-names></name><name><surname>Holscher</surname><given-names>C</given-names></name></person-group><year>2007</year><article-title>Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background.</article-title><source>Exp Brain Res</source><volume>179</volume><fpage>621</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">17171334</pub-id></citation></ref><ref id="pone.0003236-Braun1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Braun</surname><given-names>H</given-names></name><name><surname>Buhnemann</surname><given-names>C</given-names></name><name><surname>Neumann</surname><given-names>J</given-names></name><name><surname>Reymann</surname><given-names>KG</given-names></name></person-group><year>2006</year><article-title>Preparation of a tissue-like cortical primary culture from embryonic rats using Matrigel and serum free Start V Medium.</article-title><source>J Neurosci Methods</source><volume>157</volume><fpage>32</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">16682083</pub-id></citation></ref><ref id="pone.0003236-Christopeit1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Christopeit</surname><given-names>T</given-names></name><name><surname>Hortschansky</surname><given-names>P</given-names></name><name><surname>Schroeckh</surname><given-names>V</given-names></name><name><surname>Guhrs</surname><given-names>K</given-names></name><name><surname>Zandomeneghi</surname><given-names>G</given-names></name><etal/></person-group><year>2005</year><article-title>Mutagenic analysis of the nucleation propensity of oxidized Alzheimer's beta-amyloid peptide.</article-title><source>Protein Sci</source><volume>14</volume><fpage>2125</fpage><lpage>2131</lpage><pub-id pub-id-type="pmid">15987892</pub-id></citation></ref><ref id="pone.0003236-Breder1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Breder</surname><given-names>J</given-names></name><name><surname>Sabelhaus</surname><given-names>CF</given-names></name><name><surname>Opitz</surname><given-names>T</given-names></name><name><surname>Reymann</surname><given-names>KG</given-names></name><name><surname>Schroder</surname><given-names>UH</given-names></name></person-group><year>2000</year><article-title>Inhibition of different pathways influencing Na(&#x0002b;) homeostasis protects organotypic hippocampal slice cultures from hypoxic/hypoglycemic injury.</article-title><source>Neuropharmacology</source><volume>39</volume><fpage>1779</fpage><lpage>1787</lpage><pub-id pub-id-type="pmid">10884559</pub-id></citation></ref><ref id="pone.0003236-Habicht1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Habicht</surname><given-names>G</given-names></name><name><surname>Haupt</surname><given-names>C</given-names></name><name><surname>Friedrich</surname><given-names>RP</given-names></name><name><surname>Hortschansky</surname><given-names>P</given-names></name><name><surname>Sachse</surname><given-names>C</given-names></name><etal/></person-group><year>2007</year><article-title>Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils.</article-title><source>Proc Natl Acad Sci U S A</source><volume>104</volume><fpage>19232</fpage><lpage>19237</lpage><pub-id pub-id-type="pmid">18042730</pub-id></citation></ref><ref id="pone.0003236-Schroder1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>UH</given-names></name><name><surname>Hock</surname><given-names>FJ</given-names></name><name><surname>Wirth</surname><given-names>K</given-names></name><name><surname>Englert</surname><given-names>HC</given-names></name><name><surname>Reymann</surname><given-names>KG</given-names></name></person-group><year>2004</year><article-title>The ATP-regulated K&#x0002b;-channel inhibitor HMR-1372 affects synaptic plasticity in hippocampal slices.</article-title><source>Eur J Pharmacol</source><volume>502</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">15464094</pub-id></citation></ref><ref id="pone.0003236-Baldauf1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baldauf</surname><given-names>K</given-names></name><name><surname>Reymann</surname><given-names>KG</given-names></name></person-group><year>2005</year><article-title>Influence of EGF/bFGF treatment on proliferation, early neurogenesis and infarct volume after transient focal ischemia.</article-title><source>Brain Res</source><volume>1056</volume><fpage>158</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">16125154</pub-id></citation></ref><ref id="pone.0003236-Paxinos1"><label>62</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname><given-names>G</given-names></name><name><surname>Watson</surname><given-names>C</given-names></name></person-group><year>1998</year><source>The Rat Brain in Stereotaxic Coordinates (fourth ed.)</source><publisher-loc>New York</publisher-loc><publisher-name>Academic Press</publisher-name></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Leibniz Institute for Neurobiology, Research Institute for Applied Neurosciences gGmbH</p></fn></fn-group></back></article> 